Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis

Our studies have demonstrated that chronic Δ(9)-tetrahydrocannabinol (THC) administration results in a generalized attenuation of viral load and tissue inflammation in simian immunodeficiency virus (SIV)-infected male rhesus macaques. Gut-associated lymphoid tissue is an important site for HIV repli...

Full description

Saved in:
Bibliographic Details
Published inAIDS research and human retroviruses Vol. 30; no. 6; p. 567
Main Authors Molina, Patricia E, Amedee, Angela M, LeCapitaine, Nicole J, Zabaleta, Jovanny, Mohan, Mahesh, Winsauer, Peter J, Vande Stouwe, Curtis, McGoey, Robin R, Auten, Matthew W, LaMotte, Lynn, Chandra, Lawrance C, Birke, Leslie L
Format Journal Article
LanguageEnglish
Published United States 01.06.2014
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Our studies have demonstrated that chronic Δ(9)-tetrahydrocannabinol (THC) administration results in a generalized attenuation of viral load and tissue inflammation in simian immunodeficiency virus (SIV)-infected male rhesus macaques. Gut-associated lymphoid tissue is an important site for HIV replication and inflammation that can impact disease progression. We used a systems approach to examine the duodenal immune environment in 4- to 6-year-old male rhesus monkeys inoculated intravenously with SIVMAC251 after 17 months of chronic THC administration (0.18-0.32 mg/kg, intramuscularly, twice daily). Duodenal tissue samples excised from chronic THC- (N=4) and vehicle (VEH)-treated (N=4) subjects at ∼5 months postinoculation showed lower viral load, increased duodenal integrin beta 7(+)(β7) CD4(+) and CD8(+) central memory T cells, and a significant preferential increase in Th2 cytokine expression. Gene array analysis identified six genes that were differentially expressed in intestinal samples of the THC/SIV animals when compared to those differentially expressed between VEH/SIV and uninfected controls. These genes were identified as having significant participation in (1) apoptosis, (2) cell survival, proliferation, and morphogenesis, and (3) energy and substrate metabolic processes. Additional analysis comparing the duodenal gene expression in THC/SIV vs. VEH/SIV animals identified 93 differentially expressed genes that participate in processes involved in muscle contraction, protein folding, cytoskeleton remodeling, cell adhesion, and cell signaling. Immunohistochemical staining showed attenuated apoptosis in epithelial crypt cells of THC/SIV subjects. Our results indicate that chronic THC administration modulated duodenal T cell populations, favored a pro-Th2 cytokine balance, and decreased intestinal apoptosis. These findings reveal novel mechanisms that may potentially contribute to cannabinoid-mediated disease modulation.
AbstractList Our studies have demonstrated that chronic Δ(9)-tetrahydrocannabinol (THC) administration results in a generalized attenuation of viral load and tissue inflammation in simian immunodeficiency virus (SIV)-infected male rhesus macaques. Gut-associated lymphoid tissue is an important site for HIV replication and inflammation that can impact disease progression. We used a systems approach to examine the duodenal immune environment in 4- to 6-year-old male rhesus monkeys inoculated intravenously with SIVMAC251 after 17 months of chronic THC administration (0.18-0.32 mg/kg, intramuscularly, twice daily). Duodenal tissue samples excised from chronic THC- (N=4) and vehicle (VEH)-treated (N=4) subjects at ∼5 months postinoculation showed lower viral load, increased duodenal integrin beta 7(+)(β7) CD4(+) and CD8(+) central memory T cells, and a significant preferential increase in Th2 cytokine expression. Gene array analysis identified six genes that were differentially expressed in intestinal samples of the THC/SIV animals when compared to those differentially expressed between VEH/SIV and uninfected controls. These genes were identified as having significant participation in (1) apoptosis, (2) cell survival, proliferation, and morphogenesis, and (3) energy and substrate metabolic processes. Additional analysis comparing the duodenal gene expression in THC/SIV vs. VEH/SIV animals identified 93 differentially expressed genes that participate in processes involved in muscle contraction, protein folding, cytoskeleton remodeling, cell adhesion, and cell signaling. Immunohistochemical staining showed attenuated apoptosis in epithelial crypt cells of THC/SIV subjects. Our results indicate that chronic THC administration modulated duodenal T cell populations, favored a pro-Th2 cytokine balance, and decreased intestinal apoptosis. These findings reveal novel mechanisms that may potentially contribute to cannabinoid-mediated disease modulation.
Author Chandra, Lawrance C
Mohan, Mahesh
Winsauer, Peter J
Auten, Matthew W
Zabaleta, Jovanny
Birke, Leslie L
McGoey, Robin R
LaMotte, Lynn
Amedee, Angela M
Molina, Patricia E
Vande Stouwe, Curtis
LeCapitaine, Nicole J
Author_xml – sequence: 1
  givenname: Patricia E
  surname: Molina
  fullname: Molina, Patricia E
  organization: Departments of Physiology, Pharmacology, and Medicine, and Alcohol and Drug Abuse Center of Excellence, Louisiana State University Health Sciences Center , New Orleans, Louisiana
– sequence: 2
  givenname: Angela M
  surname: Amedee
  fullname: Amedee, Angela M
– sequence: 3
  givenname: Nicole J
  surname: LeCapitaine
  fullname: LeCapitaine, Nicole J
– sequence: 4
  givenname: Jovanny
  surname: Zabaleta
  fullname: Zabaleta, Jovanny
– sequence: 5
  givenname: Mahesh
  surname: Mohan
  fullname: Mohan, Mahesh
– sequence: 6
  givenname: Peter J
  surname: Winsauer
  fullname: Winsauer, Peter J
– sequence: 7
  givenname: Curtis
  surname: Vande Stouwe
  fullname: Vande Stouwe, Curtis
– sequence: 8
  givenname: Robin R
  surname: McGoey
  fullname: McGoey, Robin R
– sequence: 9
  givenname: Matthew W
  surname: Auten
  fullname: Auten, Matthew W
– sequence: 10
  givenname: Lynn
  surname: LaMotte
  fullname: LaMotte, Lynn
– sequence: 11
  givenname: Lawrance C
  surname: Chandra
  fullname: Chandra, Lawrance C
– sequence: 12
  givenname: Leslie L
  surname: Birke
  fullname: Birke, Leslie L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24400995$$D View this record in MEDLINE/PubMed
BookMark eNo1kLtOxDAQRS0EgmWhpEUuochi57Eb0614rgSigRqN7TExiu0lTkD5Lyo-gm_CvKq5unN052p2yaYPHgk54GzGWS1OlqvzWc54MWO8zjfIhIuCZ3XJqh2yG-MzY0zkebVNdvKyTFpUE_JxG_TQQm-Dp8HQp6HP4hqVNVZRh6oBb6OLVI5UNV3wyf18PxLHWY99B82ou6DAe5DWh5aCdjbxafOTZz110CLtGoxDTFrBy4Ax-QZVj5q-2b6h0ToLCXZu8EFjOmzRq5G-2m6IpxRoHGOP3x1saMPTSMFDO0Yb98iWgTbi_t-ckofLi_uz6-zm7mp1trzJ1jnnfSZMJVghq4UURWFKprhUWEO5mBf1vBIGpBRVURqtuUYhmGESWKkTinK-qEU-JYe_uetBOtSP68466MbH_yfmX39gel4
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1089/AID.2013.0182
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1931-8405
ExternalDocumentID 24400995
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: P20 GM103501
– fundername: NIGMS NIH HHS
  grantid: P20GM103501
– fundername: NIDA NIH HHS
  grantid: R01 DA030053-04
– fundername: PHS HHS
  grantid: NIDA-020419-01A1
– fundername: NIDA NIH HHS
  grantid: R01 DA020419
– fundername: NIH HHS
  grantid: P51 OD011104
GroupedDBID ---
-~X
.55
.GJ
0R~
1CY
23M
34G
39C
4.4
53G
5GY
5RE
6J9
ABBKN
ABJNI
ACGFO
ACGFS
ACPRK
ADBBV
AENEX
AFFNX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BNQNF
CAG
CGR
COF
CS3
CUY
CVF
EBS
ECM
EIF
EJD
F5P
IAO
IH2
IHR
IM4
INH
INR
ITC
L7B
MV1
N8Y
NPM
NQHIM
O9-
P2P
RIG
RML
RMSOB
UAP
UE5
X7M
ZGI
ID FETCH-LOGICAL-p211t-9f5903b57b933f40c1bce8a47638659fabb9534fdd1de990f0ba04d3f4eb67892
IngestDate Thu Apr 03 06:57:47 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p211t-9f5903b57b933f40c1bce8a47638659fabb9534fdd1de990f0ba04d3f4eb67892
PMID 24400995
ParticipantIDs pubmed_primary_24400995
PublicationCentury 2000
PublicationDate 2014-Jun
PublicationDateYYYYMMDD 2014-06-01
PublicationDate_xml – month: 06
  year: 2014
  text: 2014-Jun
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle AIDS research and human retroviruses
PublicationTitleAlternate AIDS Res Hum Retroviruses
PublicationYear 2014
References 18493729 - J Mol Med (Berl). 2008 Aug;86(8):925-36
17338855 - Curr HIV/AIDS Rep. 2007 Feb;4(1):10-5
8101865 - J Exp Med. 1993 Aug 1;178(2):743-7
10734163 - J Pharmacol Exp Ther. 2000 Apr;293(1):136-50
15708990 - J Virol. 2005 Mar;79(5):2709-19
22135307 - Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G565-71
22922252 - J Clin Invest. 2012 Sep;122(9):3059-62
16083701 - Gastroenterology. 2005 Aug;129(2):437-53
11079717 - Cell Tissue Res. 2000 Oct;302(1):73-80
22442067 - J Neurosci. 2012 Mar 21;32(12):4004-16
21463073 - Exp Clin Psychopharmacol. 2011 Apr;19(2):154-72
11672577 - Eur J Pharmacol. 2001 Aug 3;425(1):73-83
9108095 - Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4005-10
16574988 - Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):G364-71
21935390 - PLoS One. 2011;6(9):e24250
12960289 - J Leukoc Biol. 2003 Oct;74(4):486-96
22669579 - Mucosal Immunol. 2012 Nov;5(6):658-69
12446015 - J Neuroimmunol. 2002 Dec;133(1-2):124-31
11859109 - J Immunol. 2002 Mar 1;168(5):2225-32
22889111 - BMC Microbiol. 2012;12:175
10843702 - J Immunol. 2000 Jun 15;164(12):6461-6
11757815 - Curr Opin Pharmacol. 2001 Dec;1(6):597-603
19079189 - Mucosal Immunol. 2008 Jul;1(4):279-88
10358771 - Annu Rev Immunol. 1999;17:657-700
20874519 - AIDS Res Hum Retroviruses. 2011 Jun;27(6):585-92
22163000 - PLoS One. 2011;6(12):e28159
12658116 - Alcohol Clin Exp Res. 2003 Mar;27(3):495-502
21399494 - Curr Opin HIV AIDS. 2011 May;6(3):221-7
17906675 - Br J Pharmacol. 2008 Jan;153(2):263-70
17115046 - Nat Med. 2006 Dec;12(12):1365-71
15793562 - Nature. 2005 Apr 28;434(7037):1148-52
18260759 - J Infect Dis. 2008 Mar 1;197(5):714-20
14741435 - J Neuroimmunol. 2004 Feb;147(1-2):91-4
9630212 - Cell. 1998 May 29;93(5):677-80
18025874 - AIDS. 2007 Nov 30;21(18):2377-85
15085199 - J Clin Invest. 2004 Apr;113(8):1202-9
21830069 - J Neuroimmune Pharmacol. 2011 Dec;6(4):516-27
21484257 - J Neuroimmune Pharmacol. 2011 Dec;6(4):540-5
20543591 - Curr Opin HIV AIDS. 2010 Mar;5(2):141-5
11514564 - J Biol Chem. 2001 Oct 26;276(43):40133-45
19408320 - Inflamm Bowel Dis. 2009 Nov;15(11):1678-85
10861074 - J Immunol. 2000 Jul 1;165(1):373-80
19053981 - Aliment Pharmacol Ther. 2009 Mar 1;29(5):542-51
8063421 - Infect Immun. 1994 Sep;62(9):4015-20
10993932 - J Gen Virol. 2000 Oct;81(Pt 10):2441-9
11358910 - Gut. 2001 Jun;48(6):859-67
9846495 - Immunity. 1998 Nov;9(5):745-55
References_xml – reference: 16083701 - Gastroenterology. 2005 Aug;129(2):437-53
– reference: 19053981 - Aliment Pharmacol Ther. 2009 Mar 1;29(5):542-51
– reference: 15793562 - Nature. 2005 Apr 28;434(7037):1148-52
– reference: 11672577 - Eur J Pharmacol. 2001 Aug 3;425(1):73-83
– reference: 21463073 - Exp Clin Psychopharmacol. 2011 Apr;19(2):154-72
– reference: 14741435 - J Neuroimmunol. 2004 Feb;147(1-2):91-4
– reference: 11514564 - J Biol Chem. 2001 Oct 26;276(43):40133-45
– reference: 22135307 - Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G565-71
– reference: 8101865 - J Exp Med. 1993 Aug 1;178(2):743-7
– reference: 12658116 - Alcohol Clin Exp Res. 2003 Mar;27(3):495-502
– reference: 8063421 - Infect Immun. 1994 Sep;62(9):4015-20
– reference: 10358771 - Annu Rev Immunol. 1999;17:657-700
– reference: 10843702 - J Immunol. 2000 Jun 15;164(12):6461-6
– reference: 18025874 - AIDS. 2007 Nov 30;21(18):2377-85
– reference: 22669579 - Mucosal Immunol. 2012 Nov;5(6):658-69
– reference: 18493729 - J Mol Med (Berl). 2008 Aug;86(8):925-36
– reference: 9846495 - Immunity. 1998 Nov;9(5):745-55
– reference: 17115046 - Nat Med. 2006 Dec;12(12):1365-71
– reference: 10734163 - J Pharmacol Exp Ther. 2000 Apr;293(1):136-50
– reference: 9108095 - Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4005-10
– reference: 19079189 - Mucosal Immunol. 2008 Jul;1(4):279-88
– reference: 22889111 - BMC Microbiol. 2012;12:175
– reference: 17906675 - Br J Pharmacol. 2008 Jan;153(2):263-70
– reference: 11757815 - Curr Opin Pharmacol. 2001 Dec;1(6):597-603
– reference: 22163000 - PLoS One. 2011;6(12):e28159
– reference: 21935390 - PLoS One. 2011;6(9):e24250
– reference: 11358910 - Gut. 2001 Jun;48(6):859-67
– reference: 12446015 - J Neuroimmunol. 2002 Dec;133(1-2):124-31
– reference: 19408320 - Inflamm Bowel Dis. 2009 Nov;15(11):1678-85
– reference: 21484257 - J Neuroimmune Pharmacol. 2011 Dec;6(4):540-5
– reference: 11859109 - J Immunol. 2002 Mar 1;168(5):2225-32
– reference: 22922252 - J Clin Invest. 2012 Sep;122(9):3059-62
– reference: 17338855 - Curr HIV/AIDS Rep. 2007 Feb;4(1):10-5
– reference: 12960289 - J Leukoc Biol. 2003 Oct;74(4):486-96
– reference: 15708990 - J Virol. 2005 Mar;79(5):2709-19
– reference: 11079717 - Cell Tissue Res. 2000 Oct;302(1):73-80
– reference: 21399494 - Curr Opin HIV AIDS. 2011 May;6(3):221-7
– reference: 10993932 - J Gen Virol. 2000 Oct;81(Pt 10):2441-9
– reference: 9630212 - Cell. 1998 May 29;93(5):677-80
– reference: 15085199 - J Clin Invest. 2004 Apr;113(8):1202-9
– reference: 16574988 - Am J Physiol Gastrointest Liver Physiol. 2006 Aug;291(2):G364-71
– reference: 10861074 - J Immunol. 2000 Jul 1;165(1):373-80
– reference: 18260759 - J Infect Dis. 2008 Mar 1;197(5):714-20
– reference: 20874519 - AIDS Res Hum Retroviruses. 2011 Jun;27(6):585-92
– reference: 22442067 - J Neurosci. 2012 Mar 21;32(12):4004-16
– reference: 21830069 - J Neuroimmune Pharmacol. 2011 Dec;6(4):516-27
– reference: 20543591 - Curr Opin HIV AIDS. 2010 Mar;5(2):141-5
SSID ssj0009225
Score 2.2340407
Snippet Our studies have demonstrated that chronic Δ(9)-tetrahydrocannabinol (THC) administration results in a generalized attenuation of viral load and tissue...
SourceID pubmed
SourceType Index Database
StartPage 567
SubjectTerms Animals
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Cytokines - secretion
Dronabinol - administration & dosage
Duodenum - pathology
Duodenum - virology
Gene Expression Profiling
Immunologic Factors - administration & dosage
Injections, Intravenous
Macaca mulatta
Male
Microarray Analysis
Simian Acquired Immunodeficiency Syndrome - drug therapy
Simian Acquired Immunodeficiency Syndrome - pathology
Simian Acquired Immunodeficiency Syndrome - virology
Simian Immunodeficiency Virus - isolation & purification
Systems Biology
T-Lymphocyte Subsets - immunology
Viral Load
Title Modulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/24400995
Volume 30
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF4lICEuiPcbzYFIoMjBjtdOllsIrUpFuNBKFZdq17sulogdxQ5S-V2c-BH8Jma86zhJi3hcLMubWOvMl5lvxvNg7Hmkk5in8dATiQmoJMf3xFgrLzCxMlwhRUkpoD_7EB8c88OT6KTT7WxkLa0qNUi-XVpX8j9SxWsoV6qS_QfJrm-KF_Ac5YtHlDAe_0rGs0K76VvE-c5WlUeFk5T8058bKunNynlJBDOxLXD7vele7w1HUil6Q-FVpkJVc67Rhsk8l-gjF1_6cqubLoVD5mhD-svPplyVeJ5IsiQuiavJXS-zOSmKjIpNCm2oK0Vd0vk1W65KW09tW0bjbtZdn2w3lE12PHn39mPftR-yFXd2hOASN1rU92ozHmf1tKF2ykAm26KKCZp4m2A0oZxd2YZ835upXNThELP-H5j21dgnqfBhLaE-LNDJcJrShUUC3qZvDYxV5SIMPHRfo01d794BZRcUd2SHglwwKD4JZB8fn7IAw4Ef2FFJG-BazGt0IU0ith39eXWnv3ez1GVd9HRodCvFm5q20ahuXWdY3MmrrX1QH2v33R2fqOZGRzfZDefUwMQi9BbrmPw2uzZzaRt32I8WqFCksAlUaIEK6hwcUOHn9xfi5aUAhW2AQpYDARQsQKEBKDQABQIoWIDCLkChBtVrkODgCQ6e0MDzLjve3zuaHnhuaIi3GAZB5Yk0En6oopESYZhyPwlUYsaSox0dx5FIpVIiCnmqdaANUrHUV9LnGj9qFBI3MbzHruRFbh4wwBulxucyGamAy1DLONW-kZwnY8SVP3rI7ttf_XRhO8OcNvJ49NuVx-x6i9Yn7GqKqsg8RV5bqWe16H8Bh6GuHw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modulation+of+gut-specific+mechanisms+by+chronic+%CE%B4%289%29-tetrahydrocannabinol+administration+in+male+rhesus+macaques+infected+with+simian+immunodeficiency+virus%3A+a+systems+biology+analysis&rft.jtitle=AIDS+research+and+human+retroviruses&rft.au=Molina%2C+Patricia+E&rft.au=Amedee%2C+Angela+M&rft.au=LeCapitaine%2C+Nicole+J&rft.au=Zabaleta%2C+Jovanny&rft.date=2014-06-01&rft.eissn=1931-8405&rft.volume=30&rft.issue=6&rft.spage=567&rft_id=info:doi/10.1089%2FAID.2013.0182&rft_id=info%3Apmid%2F24400995&rft_id=info%3Apmid%2F24400995&rft.externalDocID=24400995